- Report
- October 2024
- 194 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- April 2024
- 137 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 125 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- September 2024
- 427 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- July 2024
- 144 Pages
Global
From €2842EUR$2,990USD£2,388GBP
- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- November 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 194 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 189 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 181 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 190 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- December 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2025
- 130 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- August 2024
- 135 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,472GBP

The Bioabsorbable Stent market is a subset of the larger Stent market. Bioabsorbable Stents are medical devices used to treat coronary artery disease. They are made of biodegradable materials that dissolve over time, allowing the artery to return to its natural state. This type of stent is advantageous over traditional metal stents, as it eliminates the need for a second procedure to remove the stent. Bioabsorbable Stents are also beneficial in that they reduce the risk of restenosis, a condition in which the artery becomes blocked again after stent placement.
Notable companies in the Bioabsorbable Stent market include Abbott, Biotronik, Elixir Medical, and Biosensors International. Show Less Read more